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ABSTRACT 
Purinergic signaling is a type of extracellular communication that occurs between cells, mediated by adenosine 
triphosphate (ATP), adenosine diphosphate (ADP), and adenosine. In Parkinson’s Disease, purinergic signaling 
is disrupted, which contributes to neurodegeneration. In order to monitor this change in cell-to-cell signaling, there 
is a need for the development of a fluorescent protein (FP) biosensor to study the changes in the concentration of 
the signaling molecule ATP and its decomposition bioproduct ADP. This summer a genetically encoded ADP 
sensor that measures changes in ADP concentration was developed. This sensor utilizes Forster Resonance 
Energy Transfer (FRET) which is a sensing technique that is based on the energy transfer from a donor FP to an 
acceptor FP. Since this transfer is distance dependent, a change in the sensing domain allows for detection of 
ADP concentration through changes in fluorescence emission. To develop this FRET based sensor, we are 
utilizing a cyan-yellow FP pair, as well as a non-fluorescent protein that binds to ADP. Using traditional cloning 
methods, a small library of ADP sensors from five different versions of both the cyan and yellow proteins was 
created. This library was screened in E. coli cultures using a method developed to optimize an ATP-sensor. The 
cloning for this sensor has been confirmed and the library is being tested for sensors responsive to changing 
concentrations of ADP. With confirmation of a responsive sensor, this sensor design will be validated, allowing for 
further optimization of this biosensor for the study of purinergic signaling and neurodegeneration. 
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